DOCSLIB.ORG

ABCA3 Is a Lamellar Body Membrane Protein in Human Lung Alveolar Type II Cells1

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
ABCA3 Is a Lamellar Body Membrane Protein in Human Lung Alveolar Type II Cells1 FEBS 25447 FEBS Letters 508 (2001) 221^225 CORE Metadata, citation and similar papers at core.ac.uk Provided by Elsevier - Publisher ConnectorABCA3 is a lamellar body membrane protein in human lung alveolar type II cells1 Gen Yamanoa, Hisayuki Funahashib, Oichi Kawanamic, Li-Xia Zhaoa, Nobuhiro Bana, Yoshiyuki Uchidad, Toshio Morohoshie, Junichi Ogawaf , Seiji Shiodab, Nobuya Inagakia;* aDepartment of Physiology, Akita University School of Medicine, 1-1-1 Hondo, Akita 010-8543, Japan bDepartment of Anatomy, Showa University School of Medicine, 1-5-8 Hatanodai, Shinagawa-Ku, Tokyo 142-8555, Japan cInstitute of Gerontology, Nippon Medical School, 1-396 Kosugi-cho, Nakahara-Ku, Kawasaki 211-8533, Japan dDepartment of Pulmonary Medicine, Institute of Clinical Medicine, University of Tsukuba, 1-1-1 Tennoudai, Tsukuba, Ibaraki 305-8375, Japan eDepartment of Pathology, Showa University School of Medicine, 1-5-8 Hatanodai, Shinagawa-Ku, Tokyo 142-8555, Japan f Department of Surgery, Akita University School of Medicine, 1-1-1 Hondo, Akita 010-8543, Japan Received 18 September 2001; revised 10 October 2001; accepted 16 October 2001 First published online 30 October 2001 Edited by Veli-Pekka Lehto Stargardt's macular dystrophy [5] in human, respectively. In Abstract The ABCA3 gene, of the ABCA subclass of ATP- binding cassette (ABC) transporters, is expressed exclusively in addition to ABCA1 and ABCA4, ¢ve other members, lung. We report here the cloning, molecular characterization, and ABCA2/ABC2 [6], ABCA3/ABC3 (ABC-C) [7,8], ABCA6 distribution of human ABCA3 in the lung. Immunoblot analysis [9], ABCA7 [10], and ABCA8 [9], have been shown to belong using the specific antibody reveals a 150-kDa protein in the crude to the ABCA subclass to date. ABCA1 and ABCA4 are pro- membrane fraction of human lung. Immunohistochemical anal- posed to be transmembrane transporters for intracellular cho- yses of alveoli show that ABCA3 is expressed only in the type II lesterol/phospholipids [3,4,11] and protonated N-retinylidene- cells expressing surfactant protein A. At the ultrastructural level, phosphatidylethanolamine [12], respectively. ABCA2, ABCA3 immunoreactivity was detected mostly at the limiting ABCA3, and ABCA7 mRNA levels have been reported to membrane of the lamellar bodies. Since members of the ABCA be upregulated by the sustained cholesterol in£ux mediated transporter family are known to be involved in transmembrane by modi¢ed low density lipoprotein [13,14], suggesting that transport of endogenous lipids, our findings suggest that ABCA3 plays an important role in the formation of pulmonary surfactant ABCA transporters including ABCA3 are involved in trans- in type II cells. ß 2001 Federation of European Biochemical membrane transport of endogenous lipids [4]. Societies. Published by Elsevier Science B.V. All rights re- ABCA3, which was originally cloned from a cDNA library served. constructed from human medullary thyroid carcinoma cell line [7] or from human genomic DNA by exon-trapping [8], Key words: ATP-binding cassette transporter; is expressed predominantly in the human lung [7,8]. However, Alveolar type II cell; Lipid transport; Surfactant; the distribution and function of ABCA3 in the lung remain Lamellar body; Surfactant protein A unknown, and it has not been cloned from lung tissues. In the present study, we cloned ABCA3 from human lung and generated a speci¢c antibody against it, and found that 1. Introduction the 150-kDa ABCA3 protein is expressed predominantly at the limiting membrane of the lamellar bodies in the type II The ATP-binding cassette (ABC) transporter superfamily is cells in human lung alveolar structures. The data suggest that one of the largest gene families, encoding highly conserved ABCA3 may play an important role in the formation of pul- proteins involved in energy-dependent transport of a variety monary surfactant, which is composed mainly of phospholip- of substrates across membrane, including ions, amino acids, ids and speci¢c surfactant proteins [15]. peptides, carbohydrates, and lipids [1]. Among the several subclasses of ABC transporters, the ABCA subclass [2] has received considerable attention because mutation of the 2. Materials and methods ABCA1/ABC1 or the ABCA4/ABCR gene causes Tangier dis- 2.1. Construction of human ABCA3 expression vector ease accompanying high density lipoprotein de¢ciency [3,4] or 7.2U105 plaques of a human lung cDNA library (Stratagene) were screened under the standard hybridization conditions [16] using DNA fragments of mouse EST clones AW900257 and AA638829, which contain the regions corresponding to the 5P-untranslated region to *Corresponding author. Fax: (81)-18-884 6442. nucleotide +1020 (relative to the putative translation start site) and E-mail address: [email protected] (N. Inagaki). nucleotide +4820 to the 3P-untranslated region of human ABCA3 cDNA, respectively, as probes. Three of the positive 71 clones, VhAB- 1 The nucleotide sequence for human ABCA3 has been deposited in CA3-5-1, VhABCA3-5-4, and VhABCA3-3-17, were subcloned and the DDBJ/EMBL/GenBank nucleotide sequence database under sequenced. In addition, to obtain the DNA fragment covering the accession number AB070929. middle region of human ABCA3, the DNA fragment from +2475 to +4313 was ampli¢ed by polymerase chain reaction (PCR) using Abbreviations: ABC, ATP-binding cassette; PCR, polymerase chain human lung cDNA (Clontech), subcloned, and sequenced. Using reaction; SP-A, surfactant protein A; PBS, phosphate-bu¡ered saline; these DNA fragments, the expression vector (pCMVhABCA3) carry- DAB, 3,3P-diaminobenzidine-4HCl ing the full-length cDNA of human ABCA3 was constructed. 0014-5793 / 01 / $20.00 ß 2001 Federation of European Biochemical Societies. Published by Elsevier Science B.V. All rights reserved. PII: S0014-5793(01)03056-3 FEBS 25447 12-11-01 Cyaan Magenta Geel Zwart 222 G. Yamano et al./FEBS Letters 508 (2001) 221^225 2.2. Tissue preparation, cell culture, and transfection Human lung tissue was obtained from adult patients undergoing surgical removal for various reasons. Culture and transfection of HEK 293 cells were carried out as previously described [17]. 2 Wgof pCMVhABCA3 or pCMV vector was transfected into cells with Lipo- fectamine and Opti-MEM I (Life Technologies, Inc.), according to the manufacturer's instructions. 2.3. Crude membrane preparation Crude membrane of transfected HEK 293 cells or human lung tissue was prepared as previously described [6,17]. Brie£y, for trans- fected HEK 293 cells, 3 days after transfection with pCMVhABCA3 or pCMV vector alone, the cells were washed, suspended in bu¡er A consisting of 50 mM Tris (pH 7.5) and 1 mM EDTA containing protease inhibitor cocktail (10 Wl/ml) (Sigma), homogenized, and then ultracentrifuged at 100 000Ug at 4³C for 1 h. The pellets were resuspended in 500 Wl of bu¡er A and stored at 380³C until immu- noblot analysis. For lung tissue, the tissue in bu¡er A (10% volume) containing protease inhibitor cocktail (10 Wl/ml) was homogenized in a Te£on pestle-glass homogenizer on ice and centrifuged at 800Ug for 7 min at 4³C. The supernatant was then subjected to ultracentrifuga- tion, and the pellet was resuspended and stored as described above. Protein concentrations were determined using the BCA assay (Pierce, Rockford, IL, USA). 2.4. Primary antibodies The speci¢c antibody for ABCA3 was raised in a rabbit against the synthetic peptide corresponding to 13 C-terminal amino acid residues (FAHLQPPTAEEGR) of human ABCA3, which di¡ers construc- Fig. 2. Immunohistochemical labeling of ABCA3 by DAB reaction of human lung tissue cryosections. A: Immunoreactive round or cu- boid cells (arrow) are scattered throughout the alveoli. B: A repre- sentative immunoreactive cell; vesicle-like structures are strongly stained on the surface (arrowhead). Scale bar, 10 Wm. tively from other ABCA transporters and any other protein from the sequence databases. The antibody was puri¢ed using a¤nity chro- matography (HiTrap Protein G, Amersham Pharmacia Biotech). For double-immuno£uorescence staining, a mouse monoclonal IgG anti- body against human surfactant protein A (SP-A, PE-10, Dako, Japan) or a mouse monoclonal antibody against Hsp-60 of mitochondria (MBL, Nagoya, Japan) was used. 2.5. Immunoblot analysis The crude membrane proteins prepared from transfected HEK 293 cells (10 Wg) and human lung tissue (20 Wg) were boiled in SDS reducing sample bu¡er, electrophoresed on 7% SDS^polyacrylamide gel, and transferred to a nitrocellulose membrane (Hybond ECL, Amersham Pharmacia Biotech) as previously described [6]. After blocking and washing [6], the membrane was incubated with 1:1000 diluted anti-ABCA3 antibody for 2 h at room temperature. After washing, the membrane was incubated with 1:5000 diluted horserad- ish peroxidase-conjugated anti-rabbit IgG (Amersham Pharmacia Bio- tech) for 1 h, followed by washing [6]. Proteins were detected using an enhanced chemiluminescence system (ECL, Amersham Pharmacia Bi- otech). 2.6. Immunohistochemistry Portions of human lung tissue were ¢xed by immersion with 4% paraformaldehyde containing 0.1% glutaraldehyde in 0.1 M phos- phate bu¡er (PB, pH 7.2) for 1 day at 4³C. After washing with 0.1 Fig. 1. Immunoblot analysis of ABC3 protein. Membrane proteins M PB, the ¢xed tissues were trimmed to smaller pieces, incubated for prepared from human lung tissue (20 Wg) (lane 1) and HEK 293 two nights in 30% sucrose in 0.1 M phosphate-bu¡ered saline (PBS), cells transfected with pCMVhABCA3 (10 Wg) (lane 2) and empty and cut into 8 Wm thick sections on a cryostat (MICROM HM 500; vector (pCMV; mock) (10 Wg) (lane 3) were electrophoresed on a MICROM, Heidelberg, Germany). The sections were rinsed with 7% SDS^polyacrylamide gel. For immunoblot analysis, an anti- PBS, preincubated with 10% normal goat serum in PBS, and then ABCA3 rabbit antibody and a horseradish peroxidase-conjugated incubated with 1:10 000 diluted anti-ABCA3 antibody.
Load more

Recommended publications
  • The Translational Expression of ABCA2 and ABCA3 Is a Strong Prognostic Biomarker for Multidrug Resistance in Pediatric Acute Lymphoblastic Leukemia
    Journal name: OncoTargets and Therapy Article Designation: Original Research Year: 2017 Volume: 10 OncoTargets and Therapy Dovepress Running head verso: Aberuyi et al Running head recto: ABCA2/A3 transporters and multidrug-resistant ALL open access to scientific and medical research DOI: http://dx.doi.org/10.2147/OTT.S140488 Open Access Full Text Article ORIGINAL RESEARCH The translational expression of ABCA2 and ABCA3 is a strong prognostic biomarker for multidrug resistance in pediatric acute lymphoblastic leukemia Narges Aberuyi1 Purpose: The aim of this work was to study the correlation between the expressions of the Soheila Rahgozar1 ABCA2 and ABCA3 genes at the mRNA and protein levels in children with acute lymphoblastic Zohreh Khosravi Dehaghi1 leukemia (ALL) and the effects of this association on multidrug resistance (MDR). Alireza Moafi2 Materials and methods: Sixty-nine children with de novo ALL and 25 controls were Andrea Masotti3,* enrolled in the study. Mononuclear cells were isolated from the bone marrow. The mRNA Alessandro Paolini3,* levels of ABCA2 and ABCA3 were measured by real-time polymerase chain reaction (PCR). Samples with high mRNA levels were assessed for respective protein levels by Western blot- 1 Department of Biology, Faculty ting. Following the first year of treatment, persistent monoclonality of T-cell gamma receptors of Science, University of Isfahan, 2Department of Pediatric- or immunoglobulin H (IgH) gene rearrangement was assessed and considered as the MDR. Hematology-Oncology, Sayed-ol- The tertiary structure of ABCA2 was predicted using Phyre2 and I-TASSER web systems Shohada Hospital, Isfahan University and compared to that of ABCA3, which has been previously reported.
    [Show full text]
  • Examining the Role of ABC Lipid Transporters in Pulmonary Lipid Homeostasis and Inflammation Amanda B
    Chai et al. Respiratory Research (2017) 18:41 DOI 10.1186/s12931-017-0526-9 REVIEW Open Access Examining the role of ABC lipid transporters in pulmonary lipid homeostasis and inflammation Amanda B. Chai1, Alaina J. Ammit2,3* and Ingrid C. Gelissen1 Abstract Respiratory diseases including asthma and chronic obstructive pulmonary disease (COPD) are characterised by excessive and persistent inflammation. Current treatments are often inadequate for symptom and disease control, and hence new therapies are warranted. Recent emerging research has implicated dyslipidaemia in pulmonary inflammation. Three ATP-binding cassette (ABC) transporters are found in the mammalian lung – ABCA1, ABCG1 and ABCA3 – that are involved in movement of cholesterol and phospholipids from lung cells. The aim of this review is to corroborate the current evidence for the role of ABC lipid transporters in pulmonary lipid homeostasis and inflammation. Here, we summarise results from murine knockout studies, human diseases associated with ABC transporter mutations, and in vitro studies. Disruption to ABC transporter activity results in lipid accumulation and elevated levels of inflammatory cytokines in lung tissue. Furthermore, these ABC-knockout mice exhibit signs of respiratory distress. ABC lipid transporters appear to have a crucial and protective role in the lung. However, our knowledge of the underlying molecular mechanisms for these benefits requires further attention. Understanding the relationship between cholesterol and inflammation in the lung, and the role that ABC transporters play in this may illuminate new pathways to target for the treatment of inflammatory lung diseases. Keywords: ABC transporters, ABCA1, ABCG1, ABCA3, Lipids, Surfactant, Pulmonary inflammation Background lung tissue of patients with COPD [5].
    [Show full text]
  • 5' Untranslated Region Elements Show High Abundance and Great
    International Journal of Molecular Sciences Article 0 5 Untranslated Region Elements Show High Abundance and Great Variability in Homologous ABCA Subfamily Genes Pavel Dvorak 1,2,* , Viktor Hlavac 2,3 and Pavel Soucek 2,3 1 Department of Biology, Faculty of Medicine in Pilsen, Charles University, 32300 Pilsen, Czech Republic 2 Biomedical Center, Faculty of Medicine in Pilsen, Charles University, 32300 Pilsen, Czech Republic; [email protected] (V.H.); [email protected] (P.S.) 3 Toxicogenomics Unit, National Institute of Public Health, 100 42 Prague, Czech Republic * Correspondence: [email protected]; Tel.: +420-377593263 Received: 7 October 2020; Accepted: 20 November 2020; Published: 23 November 2020 Abstract: The 12 members of the ABCA subfamily in humans are known for their ability to transport cholesterol and its derivatives, vitamins, and xenobiotics across biomembranes. Several ABCA genes are causatively linked to inborn diseases, and the role in cancer progression and metastasis is studied intensively. The regulation of translation initiation is implicated as the major mechanism in the processes of post-transcriptional modifications determining final protein levels. In the current bioinformatics study, we mapped the features of the 50 untranslated regions (50UTR) known to have the potential to regulate translation, such as the length of 50UTRs, upstream ATG codons, upstream open-reading frames, introns, RNA G-quadruplex-forming sequences, stem loops, and Kozak consensus motifs, in the DNA sequences of all members of the subfamily. Subsequently, the conservation of the features, correlations among them, ribosome profiling data as well as protein levels in normal human tissues were examined. The 50UTRs of ABCA genes contain above-average numbers of upstream ATGs, open-reading frames and introns, as well as conserved ones, and these elements probably play important biological roles in this subfamily, unlike RG4s.
    [Show full text]
  • Molecular Structure of a Novel Cholesterol-Responsive a Subclass ABC Transporter, ABCA9
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by University of Regensburg Publication Server BBRC Biochemical and Biophysical Research Communications 295 (2002) 408–416 www.academicpress.com Molecular structure of a novel cholesterol-responsive A subclass ABC transporter, ABCA9 Armin Piehler,1 Wolfgang E. Kaminski,1 Juurgen€ J. Wenzel, Thomas Langmann, and Gerd Schmitz* Institute for Clinical Chemistry and Laboratory Medicine, University of Regensburg, Franz-Josef-Strauß-Allee 11, D-93042, Regensburg, Germany Received 25 May 2002 Abstract We recently identified a novel ABC A subclass transporter, ABCA6, in human macrophages. Here, we report the molecular cloning of an additional ABC A subfamily transporter from macrophages denoted ABCA9. The identified coding sequence is 4.9 kb in size and codes for a 1624 amino acid protein product. In accordance with the proposed nomenclature, the novel transporter was designated ABCA9. The putative full-length ABC transporter polypeptide consists of two transmembrane domains and two nu- cleotide binding folds and thus conforms to the group of full-size ABC transporters. We identified alternative ABCA9 mRNA variants in human macrophages that predict the existence of three truncated forms of the novel transporter. Among the human ABC A subfamily transporters, ABCA9 exhibits the highest amino acid sequence homology with ABCA8 (72%) and ABCA6 (60%), respectively. The striking amino acid sequence similarity between these transporter molecules supports the notion that they represent an evolutionary more recently emerged subgroup within the family of ABC A transporters, which we refer to as ‘‘ABCA6-like transporters.’’ ABCA9 mRNA is ubiquitously expressed with the highest mRNA levels in heart, brain, and fetal tissues.
    [Show full text]
  • Transcriptional and Post-Transcriptional Regulation of ATP-Binding Cassette Transporter Expression
    Transcriptional and Post-transcriptional Regulation of ATP-binding Cassette Transporter Expression by Aparna Chhibber DISSERTATION Submitted in partial satisfaction of the requirements for the degree of DOCTOR OF PHILOSOPHY in Pharmaceutical Sciences and Pbarmacogenomies in the Copyright 2014 by Aparna Chhibber ii Acknowledgements First and foremost, I would like to thank my advisor, Dr. Deanna Kroetz. More than just a research advisor, Deanna has clearly made it a priority to guide her students to become better scientists, and I am grateful for the countless hours she has spent editing papers, developing presentations, discussing research, and so much more. I would not have made it this far without her support and guidance. My thesis committee has provided valuable advice through the years. Dr. Nadav Ahituv in particular has been a source of support from my first year in the graduate program as my academic advisor, qualifying exam committee chair, and finally thesis committee member. Dr. Kathy Giacomini graciously stepped in as a member of my thesis committee in my 3rd year, and Dr. Steven Brenner provided valuable input as thesis committee member in my 2nd year. My labmates over the past five years have been incredible colleagues and friends. Dr. Svetlana Markova first welcomed me into the lab and taught me numerous laboratory techniques, and has always been willing to act as a sounding board. Michael Martin has been my partner-in-crime in the lab from the beginning, and has made my days in lab fly by. Dr. Yingmei Lui has made the lab run smoothly, and has always been willing to jump in to help me at a moment’s notice.
    [Show full text]
  • ABC Transporter Activity Linked to Radiation Resistance And
    Ingram et al. Experimental Hematology & Oncology 2013, 2:26 http://www.ehoonline.org/content/2/1/26 Experimental Hematology & Oncology RESEARCH Open Access ABC transporter activity linked to radiation resistance and molecular subtype in pediatric medulloblastoma Wendy J Ingram1,2,4*,LisaMCrowther1, Erica B Little1,RuthFreeman1, Ivon Harliwong1, Desi Veleva1, Timothy E Hassall2, Marc Remke3, Michael D Taylor3 and Andrew R Hallahan1,2 Abstract Background: Resistance to radiation treatment remains a major clinical problem for patients with brain cancer. Medulloblastoma is the most common malignant brain tumor of childhood, and occurs in the cerebellum. Though radiation treatment has been critical in increasing survival rates in recent decades, the presence of resistant cells in a substantial number of medulloblastoma patients leads to relapse and death. Methods: Using the established medulloblastoma cell lines UW228 and Daoy, we developed a novel model system to enrich for and study radiation tolerant cells early after radiation exposure. Using fluorescence-activated cell sorting, dead cells and cells that had initiated apoptosis were removed, allowing surviving cells to be investigated before extensive proliferation took place. Results: Isolated surviving cells were tumorigenic in vivo and displayed elevated levels of ABCG2, an ABC transporter linked to stem cell behavior and drug resistance. Further investigation showed another family member, ABCA1, was also elevated in surviving cells in these lines, as well as in early passage cultures from pediatric medulloblastoma patients. We discovered that the multi-ABC transporter inhibitors verapamil and reserpine sensitized cells from particular patients to radiation, suggesting that ABC transporters have a functional role in cellular radiation protection.
    [Show full text]
  • Interindividual Differences in the Expression of ATP-Binding
    Supplemental material to this article can be found at: http://dmd.aspetjournals.org/content/suppl/2018/02/02/dmd.117.079061.DC1 1521-009X/46/5/628–635$35.00 https://doi.org/10.1124/dmd.117.079061 DRUG METABOLISM AND DISPOSITION Drug Metab Dispos 46:628–635, May 2018 Copyright ª 2018 by The American Society for Pharmacology and Experimental Therapeutics Special Section on Transporters in Drug Disposition and Pharmacokinetic Prediction Interindividual Differences in the Expression of ATP-Binding Cassette and Solute Carrier Family Transporters in Human Skin: DNA Methylation Regulates Transcriptional Activity of the Human ABCC3 Gene s Tomoki Takechi, Takeshi Hirota, Tatsuya Sakai, Natsumi Maeda, Daisuke Kobayashi, and Ichiro Ieiri Downloaded from Department of Clinical Pharmacokinetics, Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan (T.T., T.H., T.S., N.M., I.I.); Drug Development Research Laboratories, Kyoto R&D Center, Maruho Co., Ltd., Kyoto, Japan (T.T.); and Department of Clinical Pharmacy and Pharmaceutical Care, Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan (D.K.) Received October 19, 2017; accepted January 30, 2018 dmd.aspetjournals.org ABSTRACT The identification of drug transporters expressed in human skin and levels. ABCC3 expression levels negatively correlated with the methylation interindividual differences in gene expression is important for understanding status of the CpG island (CGI) located approximately 10 kilobase pairs the role of drug transporters in human skin. In the present study, we upstream of ABCC3 (Rs: 20.323, P < 0.05). The reporter gene assay revealed evaluated the expression of ATP-binding cassette (ABC) and solute carrier a significant increase in transcriptional activity in the presence of CGI.
    [Show full text]
  • Whole-Exome Sequencing Identifies Novel Mutations in ABC Transporter
    Liu et al. BMC Pregnancy and Childbirth (2021) 21:110 https://doi.org/10.1186/s12884-021-03595-x RESEARCH ARTICLE Open Access Whole-exome sequencing identifies novel mutations in ABC transporter genes associated with intrahepatic cholestasis of pregnancy disease: a case-control study Xianxian Liu1,2†, Hua Lai1,3†, Siming Xin1,3, Zengming Li1, Xiaoming Zeng1,3, Liju Nie1,3, Zhengyi Liang1,3, Meiling Wu1,3, Jiusheng Zheng1,3* and Yang Zou1,2* Abstract Background: Intrahepatic cholestasis of pregnancy (ICP) can cause premature delivery and stillbirth. Previous studies have reported that mutations in ABC transporter genes strongly influence the transport of bile salts. However, to date, their effects are still largely elusive. Methods: A whole-exome sequencing (WES) approach was used to detect novel variants. Rare novel exonic variants (minor allele frequencies: MAF < 1%) were analyzed. Three web-available tools, namely, SIFT, Mutation Taster and FATHMM, were used to predict protein damage. Protein structure modeling and comparisons between reference and modified protein structures were performed by SWISS-MODEL and Chimera 1.14rc, respectively. Results: We detected a total of 2953 mutations in 44 ABC family transporter genes. When the MAF of loci was controlled in all databases at less than 0.01, 320 mutations were reserved for further analysis. Among these mutations, 42 were novel. We classified these loci into four groups (the damaging, probably damaging, possibly damaging, and neutral groups) according to the prediction results, of which 7 novel possible pathogenic mutations were identified that were located in known functional genes, including ABCB4 (Trp708Ter, Gly527Glu and Lys386Glu), ABCB11 (Gln1194Ter, Gln605Pro and Leu589Met) and ABCC2 (Ser1342Tyr), in the damaging group.
    [Show full text]
  • Identification of Novel Rare ABCC1 Transporter Mutations in Tumor
    cells Article Identification of Novel Rare ABCC1 Transporter Mutations in Tumor Biopsies of Cancer Patients Onat Kadioglu 1, Mohamed Saeed 1, Markus Munder 2, Andreas Spuller 3, Henry Johannes Greten 4,5 and Thomas Efferth 1,* 1 Department of Pharmaceutical Biology, Institute of Pharmacy and Biochemistry, Johannes Gutenberg University, 55128 Mainz, Germany; [email protected] (O.K.); [email protected] (M.S.) 2 Third Department of Medicine (Hematology, Oncology, and Pneumology), University Medical Center of the Johannes Gutenberg University Mainz, 55131 Mainz, Germany; [email protected] 3 Clinic for Gynecology and Obstetrics, 76131 Karlsruhe, Germany; [email protected] 4 Abel Salazar Biomedical Sciences Institute, University of Porto, 4099-030 Porto, Portugal; [email protected] 5 Heidelberg School of Chinese Medicine, 69126 Heidelberg, Germany * Correspondence: eff[email protected]; Tel.: +49-6131-392-5751; Fax: 49-6131-392-3752 Received: 30 December 2019; Accepted: 23 January 2020; Published: 26 January 2020 Abstract: The efficiency of chemotherapy drugs can be affected by ATP-binding cassette (ABC) transporter expression or by their mutation status. Multidrug resistance is linked with ABC transporter overexpression. In the present study, we performed rare mutation analyses for 12 ABC transporters related to drug resistance (ABCA2, -A3, -B1, -B2, -B5, -C1, -C2, -C3, -C4, -C5, -C6, -G2) in a dataset of 18 cancer patients. We focused on rare mutations resembling tumor heterogeneity of ABC transporters in small tumor subpopulations. Novel rare mutations were found in ABCC1, but not in the other ABC transporters investigated. Diverse ABCC1 mutations were found, including nonsense mutations causing premature stop codons, and compared with the wild-type protein in terms of their protein structure.
    [Show full text]
  • Prognostic Value of ABCA2 and ABCA3 Genes Expression in Pediatric Acute Lymphoblastic Leukemia Amira Al-Ramlawy*, Hanaa Abdel-Masseih, Raida S
    International Journal of Scientific & Engineering Research Volume 10, Issue 3, March-2019 1368 ISSN 2229-5518 Prognostic value of ABCA2 and ABCA3 Genes expression in pediatric Acute Lymphoblastic Leukemia Amira Al-Ramlawy*, Hanaa Abdel-masseih, Raida S. Yahya , Camelia Abdel-Malak Abstract— Acute lymphoblastic leukemia (ALL) is a highly aggressive hematological-malignancy resulting from the proliferation and expansion of lymphoid blasts in the blood, bone marrow and other organs. Multidrug resistance (MDR) is an important cause of treatment failure in ALL. The role of ABCA2 and ABCA3 in drug transport is not entirely clear, but much of the evidence suggests that these carrier proteins have a role in MDR by causing an accumulation of drugs in the lysosomes and possibly their efflux from the cell. Aims: The aim of this work was to study and investigate the mRNA expression profile of ABCA2, ABCA3 in newly diagnosed children with ALL and healthy children, and evaluate their prognostic value to disease outcome. Subjects and Methods: This study was carried out on 50 newly diagnosed children with ALL, with age ranged from 2-18 years and 20 healthy children with matching in age and sex. Mononuclear cells were isolated from the bone marrow and peripheral blood for patients. Evaluation of gene expression for ABCA2 and ABCA3 genes using quantitative real- time polymerase chain reaction (qRT-PCR), for all groups. Complete Blood Picture, liver, kidney function tests, and serum LDH were measured using investigated measurements. Results: There was a significant difference of the ABCA2 and ABCA3 levels among different groups of ALL (patients and control group) at (P < 0.05).
    [Show full text]
  • ATP-Binding Cassette (ABC) Transporter Recessive Mutations in Biliary Atresia Cases
    PgmNr 1953: ATP-binding cassette (ABC) transporter recessive mutations in biliary atresia cases. Authors: W.Y. Lam 1,2; J.S. Hsu 3; C.S. Tang 1,2; M.T. So 1; P.H.Y. Chung 1; P.K.H. Tam 1,2; M.M. Garcia-Barcelo 1,2 View Session Add to Schedule Affiliations: 1) Department of Surgery, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong; 2) Dr Li Dak-Sum Research Centre, The University of Hong Kong – Karolinska Institutet Collaboration in Regenerative Medicine, The University of Hong Kong, Hong Kong; 3) Department of Psychiatry, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Biliary atresia (BA) is an aggressive neonatal disorder characterized by progressive fibrosclerosing obliteration of the extrahepatic biliary tract in a few weeks after birth. Early surgical intervention by Kasai portoenterostomy to establish bile flow is critical to survival, yet disease progression to liver cirrhosis occurs in many patients, leaving liver transplantation the only option. BA has the highest prevalence of 1/5000 live births in the Southeast Asian population, 3 to 4 times higher than the US and European populations. Pathogenesis of BA remains uncertain. Consistent and robust evidence supporting theories of viral infection, immune dysregulation, environmental and multifactorial causes are yet to be established. Multiple genetic studies in different ethnic groups have identified ADD3 as a susceptibility gene of BA, yet disease-causal genetic risk factor is still in search. We conducted a whole exome sequencing study on 83 trios from the Southeast Asian population, and identified 148 rare non-synonymous de novo and inherited recessive mutations in 135 genes that were predicted to be damaging, and expressed in liver or bile duct tissues according to public databases and in-house BA liver organoid gene expression dataset.
    [Show full text]
  • SALL4, a Stem Cell Factor, Affects the Side Population by Regulation of the ATP- Binding Cassette Drug Transport Genes
    SALL4, a Stem Cell Factor, Affects the Side Population by Regulation of the ATP- Binding Cassette Drug Transport Genes The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters Citation Jeong, Ha-Won, Wei Cui, Youyang Yang, Jiayun Lu, Jie He, Ailing Li, David Song, Ye Guo, Bee H. Liu, and Li Chai. 2011. SALL4, a stem cell factor, affects the side population by regulation of the ATP- binding cassette drug transport genes. PLoS ONE 6(4): e18372. Published Version doi:10.1371/journal.pone.0018372 Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:5360616 Terms of Use This article was downloaded from Harvard University’s DASH repository, and is made available under the terms and conditions applicable to Other Posted Material, as set forth at http:// nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of- use#LAA SALL4, a Stem Cell Factor, Affects the Side Population by Regulation of the ATP-Binding Cassette Drug Transport Genes Ha-Won Jeong1., Wei Cui2., Youyang Yang1, Jiayun Lu1, Jie He1, Ailing Li1, David Song1, Ye Guo2, Bee H. Liu3, Li Chai1* 1 The Department of Pathology, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts, United States of America, 2 Department of Clinical Laboratory, Chinese Academy of Medical Sciences, Peking Union Medical College Hospital, Beijing, China, 3 Centre for Life Sciences, Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore Abstract Our previous work shows that the stem cell factor SALL4 plays a central role in embryonic and leukemic stem cells.
    [Show full text]